Skip to content

Clinical trials

Leishmaniasis, Visceral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leishmaniasis, Visceral Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20051
20063
20077
20083
20094
20103
20113
20121
20132
20145
20152
20161
20171
20184
20192
20202
20211
20223
20232
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting7
Terminated7
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Drugs for Neglected Diseases10
Banaras Hindu University8
Institute of Tropical Medicine, Belgium6
International Centre for Diarrhoeal Disease Research, Bangladesh5
Foundation for Innovative New Diagnostics, Switzerland4
PATH3
Access to Advanced Health Institute (AAHI)2
National Institute of Allergy and Infectious Diseases (NIAID)2
Sichuan Huiyu Pharmaceutical Co., Ltd2
University of Brasilia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leishmaniasis, Visceral61
Leishmaniasis9
Leishmaniasis, Cutaneous4
Acquired Immunodeficiency Syndrome2
Brucellosis2
Disease2
Febrile Neutropenia2
Invasive Fungal Infections2
Leishmaniasis, Mucocutaneous2
Malnutrition2

Trials

Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.